Pulse Biosciences (PLSE) Accumulated Expenses (2015 - 2025)

Pulse Biosciences' Accumulated Expenses history runs 11 years deep, the most recent figure standing at $2.0 million for Q4 2025.

• In Q4 2025, Accumulated Expenses fell 71.84% year-over-year to $2.0 million; the TTM figure through Dec 2025 stood at $2.0 million (down 71.84% YoY), while the FY2025 annual figure was $2.0 million, down 71.84% from the prior year.
• Accumulated Expenses was $2.0 million for Q4 2025 at Pulse Biosciences, down from $5.2 million in the prior quarter.
• In the past five years, Accumulated Expenses ranged from a high of $7.0 million in Q4 2024 to a low of $27000.0 in Q3 2021.
• Historically, Accumulated Expenses has averaged $2.6 million across 5 years, with a median of $2.6 million in 2022.
• The sharpest annual moves came in 2021 and 2024: Accumulated Expenses tumbled 99.34% in 2021, then surged 3466.0% in 2024.
• A 5-year view of Accumulated Expenses shows it stood at $3.8 million in 2021, then tumbled by 31.96% to $2.6 million in 2022, then tumbled by 98.07% to $50000.0 in 2023, then soared by 13954.0% to $7.0 million in 2024, then slumped by 71.84% to $2.0 million in 2025.
• The last three Accumulated Expenses figures came in at $2.0 million (Q4 2025), $5.2 million (Q3 2025), and $3.5 million (Q2 2025), per Business Quant data.